Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Rosa Rapuano Lembo"'
Autor:
Margherita Passariello, Speranza Esposito, Lorenzo Manna, Rosa Rapuano Lembo, Immacolata Zollo, Emanuele Sasso, Felice Amato, Claudia De Lorenzo
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 12, p 10053 (2023)
The recent pandemic years have prompted the scientific community to increasingly search for and adopt new and more efficient therapeutic and diagnostic approaches to deal with a new infection. In addition to the development of vaccines, which has pla
Externí odkaz:
https://doaj.org/article/713d9678c5a141d3aa03f3c95be878f2
Autor:
Margherita Passariello, Veronica Ferrucci, Emanuele Sasso, Lorenzo Manna, Rosa Rapuano Lembo, Stefano Pascarella, Giovanna Fusco, Nicola Zambrano, Massimo Zollo, Claudia De Lorenzo
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 10, p 5556 (2022)
The dramatic experience with SARS-CoV-2 has alerted the scientific community to be ready to face new epidemics/pandemics caused by new variants. Among the therapies against the pandemic SARS-CoV-2 virus, monoclonal Antibodies (mAbs) targeting the Spi
Externí odkaz:
https://doaj.org/article/80e7e43aac304e90a10b58a6b7e3cb11
Autor:
Margherita Passariello, Asami Yoshioka, Kota Takahashi, Shu-ichi Hashimoto, Rosa Rapuano Lembo, Lorenzo Manna, Koji Nakamura, Claudia De Lorenzo
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 7, p 3466 (2022)
Cancer immunotherapy has already shown significant improvements by combining different antibodies specific for distinct immune checkpoints, such as Ipilimumab and Nivolumab. Here, we tested combinatorial treatments of immunomodulatory antibodies, pre
Externí odkaz:
https://doaj.org/article/7dda204554844f5cb7b784761c02a5d5
Autor:
Lorenzo, Margherita Passariello, Speranza Esposito, Lorenzo Manna, Rosa Rapuano Lembo, Immacolata Zollo, Emanuele Sasso, Felice Amato, Claudia De
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 12; Pages: 10053
The recent pandemic years have prompted the scientific community to increasingly search for and adopt new and more efficient therapeutic and diagnostic approaches to deal with a new infection. In addition to the development of vaccines, which has pla
Autor:
Cinzia Vetrei, Margherita Passariello, Guendalina Froechlich, Rosa Rapuano Lembo, Emanuele Sasso, Nicola Zambrano, Claudia De Lorenzo
Publikováno v:
Cancers, Vol 14, Iss 121, p 121 (2022)
Cancers
Cancers; Volume 14; Issue 1; Pages: 121
Cancers
Cancers; Volume 14; Issue 1; Pages: 121
Simple Summary Immunotherapy has revolutionized the management of cancer by improving outcomes of triple-negative breast cancer (TNBC). Recently, programmed death-ligand 1 (PD-L1), was identified as a target for TNBC and several preclinical and clini
Autor:
Rosa Rapuano Lembo, Lorenzo Manna, Guendalina Froechlich, Emanuele Sasso, Margherita Passariello, Claudia De Lorenzo
Publikováno v:
Cancers; Volume 14; Issue 21; Pages: 5289
Antibody-based cancer immunotherapy includes monoclonals against immune checkpoints (ICs), to modulate specific T cell responses against cancer. NK cells are a newly emerging target for immune checkpoint receptor inhibition in cancer immunotherapy, a
Autor:
Margherita Passariello, Nicola Zambrano, Guendalina Froechlich, Cinzia Vetrei, Rosa Rapuano Lembo, Claudia De Lorenzo
Publikováno v:
Cancers, Vol 13, Iss 2858, p 2858 (2021)
Cancers
Volume 13
Issue 12
Cancers
Volume 13
Issue 12
Simple Summary A novel challenge in cancer immunotherapy is the identification of the most potent combinations of immunomodulatory mAbs that are capable of maximizing therapeutic benefits while minimizing irAEs. We set up an in vitro system to quickl